We found that the ratio of tumor-infiltrating MHC II high to MHC II low macrophages was skewed toward an MHC II high response in mice injected with A1–mIL-12 + aPD1 compared to PBS + aPD1 or A1-ZsG (Fig. 6E). The gene discussed is PATZ1; the disease is neoplasm.